Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4840541

Brc1cnc2[nH]c(-c3ccc(OCCNCc4cccnc4)cc3)nc2c1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR5A P47898 3/20 0.42
NAMPT P43490 1/20 0.42
HRH4 Q9H3N8 1/20 0.41
DHODH Q02127 1/20 0.40
HTR1A P08908 1/20 0.39
DRD2 P14416 1/20 0.39
DRD4 P21917 1/20 0.39
HTR1D P28221 1/20 0.39
HTR1B P28222 1/20 0.39
HTR2A P28223 1/20 0.39
HTR2C P28335 1/20 0.39
HTR7 P34969 1/20 0.39
ADRA1B P35368 1/20 0.39
DRD3 P35462 1/20 0.39
HTR2B P41595 1/20 0.39
MMP13 P45452 1/20 0.39
KDM4E B2RXH2 1/20 0.38
ADRA2C P18825 1/20 0.38
APAF1 O14727 1/20 0.38
PABPC1 P11940 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL4842803 0.92 KMT2A (0.45) DRD4KDM4EKMT2AHDAC3HDAC4
SCHEMBL4838750 0.92 HRH4 (0.44) NAMPTHRH4DHODHDRD4HTR2A
Trifluoroacetic Acid SCHEMBL4844131 0.91 HDAC6 (0.39) HTR5ADHODHDRD4KMT2AHDAC3
SCHEMBL6220332 0.89 HRH4 (0.41) NAMPTHRH4DRD4HTR2AHTR2C
Trifluoroacetic Acid SCHEMBL4846811 0.88 ALDH1A1 (0.41) DHODHMMP13KMT2AADRB1ADRB3
Trifluoroacetic Acid SCHEMBL4837280 0.88 CDK4 (0.40) DRD2DRD4DRD3KMT2AHDAC3
Trifluoroacetic Acid SCHEMBL4843769 0.87 KMT2A (0.43) HTR5AMMP13KDM4EKMT2AHDAC3
Trifluoroacetic Acid SCHEMBL4842215 0.87 HDAC6 (0.41) DRD2DRD4DRD3KMT2AHDAC6
Trifluoroacetic Acid SCHEMBL4840737 0.87 HDAC6 (0.44) KDM4EHDAC3HDAC4HDAC1HDAC7
SCHEMBL4839100 0.85 PPARG (0.49) DRD2DRD4ADRA1BDRD3KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7410966-B2 Use of and some novel imidazopyridines ASTRAZENECA AB (SE) 2008-08-12 US disclosed
EP-1539759-B1 NOVEL IMIDAZOPYRIDINES AND THEIR USE ASTRAZENECA AB (SE) 2007-08-15 EP disclosed
US-20050261333-A1 Use of and some novel imidazopyridines ASTRAZENECA A B (SE) 2005-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050261333-A1 Use of and some novel imidazopyridines ITK, CSNK1A1, RPS6KA1 HTR5A 3575/4885NAMPT 2385/4885HRH4 273/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.